TrialPediatric blood & cancer2015

Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children's Oncology Group.

Elliot Stieglitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.